Concepts (76)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genetic Vectors | 8 | 2025 | 807 | 1.790 |
Why?
|
| Dependovirus | 9 | 2025 | 652 | 1.160 |
Why?
|
| Brachytherapy | 2 | 2024 | 38 | 0.900 |
Why?
|
| Brain Neoplasms | 3 | 2024 | 305 | 0.850 |
Why?
|
| Central Nervous System | 5 | 2023 | 193 | 0.840 |
Why?
|
| Spinal Cord Injuries | 1 | 2022 | 38 | 0.800 |
Why?
|
| Genetic Therapy | 6 | 2025 | 733 | 0.800 |
Why?
|
| Glioblastoma | 2 | 2024 | 155 | 0.800 |
Why?
|
| Neuroprotective Agents | 1 | 2022 | 72 | 0.780 |
Why?
|
| Muscular Atrophy, Spinal | 1 | 2022 | 19 | 0.760 |
Why?
|
| Canavan Disease | 2 | 2023 | 11 | 0.760 |
Why?
|
| Transduction, Genetic | 4 | 2020 | 228 | 0.650 |
Why?
|
| Gene Transfer Techniques | 3 | 2025 | 303 | 0.600 |
Why?
|
| Amidohydrolases | 1 | 2017 | 35 | 0.540 |
Why?
|
| Gene Expression | 1 | 2019 | 808 | 0.490 |
Why?
|
| Metabolic Diseases | 1 | 2016 | 54 | 0.480 |
Why?
|
| Nervous System Diseases | 1 | 2016 | 104 | 0.450 |
Why?
|
| Capsid Proteins | 2 | 2020 | 92 | 0.310 |
Why?
|
| Clinical Trials as Topic | 2 | 2020 | 441 | 0.240 |
Why?
|
| Mutation | 2 | 2022 | 2452 | 0.190 |
Why?
|
| Oligodendroglia | 2 | 2023 | 33 | 0.190 |
Why?
|
| Spinal Cord | 1 | 2022 | 195 | 0.190 |
Why?
|
| Serogroup | 2 | 2020 | 32 | 0.180 |
Why?
|
| Cesium Radioisotopes | 1 | 2020 | 2 | 0.180 |
Why?
|
| Mice | 6 | 2023 | 10251 | 0.170 |
Why?
|
| Gene Editing | 2 | 2022 | 299 | 0.170 |
Why?
|
| Skull Neoplasms | 1 | 2020 | 7 | 0.170 |
Why?
|
| Humans | 10 | 2025 | 59282 | 0.170 |
Why?
|
| Hemangiosarcoma | 1 | 2020 | 23 | 0.170 |
Why?
|
| Animals | 9 | 2025 | 19601 | 0.170 |
Why?
|
| Capsid | 1 | 2020 | 88 | 0.160 |
Why?
|
| Combined Modality Therapy | 1 | 2020 | 355 | 0.160 |
Why?
|
| Neoplasm Staging | 1 | 2020 | 452 | 0.160 |
Why?
|
| Infusions, Intravenous | 1 | 2019 | 164 | 0.150 |
Why?
|
| Disease Management | 1 | 2020 | 221 | 0.150 |
Why?
|
| Genes, Recessive | 1 | 2018 | 49 | 0.150 |
Why?
|
| Transgenes | 1 | 2019 | 177 | 0.150 |
Why?
|
| Heterozygote | 1 | 2018 | 161 | 0.150 |
Why?
|
| Genetic Engineering | 1 | 2019 | 111 | 0.140 |
Why?
|
| Aspartic Acid | 1 | 2017 | 28 | 0.140 |
Why?
|
| Tropism | 1 | 2017 | 16 | 0.140 |
Why?
|
| Alleles | 1 | 2018 | 410 | 0.140 |
Why?
|
| Corneal Diseases | 1 | 2016 | 3 | 0.130 |
Why?
|
| Corneal Stroma | 1 | 2016 | 7 | 0.130 |
Why?
|
| Blood-Brain Barrier | 1 | 2017 | 81 | 0.130 |
Why?
|
| Promoter Regions, Genetic | 1 | 2019 | 650 | 0.130 |
Why?
|
| Prognosis | 1 | 2020 | 1599 | 0.130 |
Why?
|
| Muscles | 1 | 2017 | 173 | 0.130 |
Why?
|
| Green Fluorescent Proteins | 1 | 2016 | 352 | 0.120 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2020 | 1525 | 0.100 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2020 | 2059 | 0.090 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 2046 | 0.080 |
Why?
|
| Treatment Outcome | 1 | 2020 | 5283 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 3 | 2020 | 3220 | 0.070 |
Why?
|
| Myelin Sheath | 1 | 2023 | 34 | 0.050 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2024 | 299 | 0.050 |
Why?
|
| Cell Lineage | 1 | 2023 | 257 | 0.050 |
Why?
|
| Mammals | 1 | 2023 | 208 | 0.050 |
Why?
|
| Virus Assembly | 1 | 2020 | 53 | 0.040 |
Why?
|
| Scalp | 1 | 2020 | 29 | 0.040 |
Why?
|
| Skull | 1 | 2020 | 50 | 0.040 |
Why?
|
| Epigenesis, Genetic | 1 | 2023 | 357 | 0.040 |
Why?
|
| DNA, Viral | 1 | 2020 | 223 | 0.040 |
Why?
|
| Phylogeny | 1 | 2020 | 336 | 0.040 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2020 | 262 | 0.040 |
Why?
|
| Cryoelectron Microscopy | 1 | 2020 | 187 | 0.040 |
Why?
|
| Injections, Intraperitoneal | 1 | 2017 | 46 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2020 | 1204 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2017 | 182 | 0.030 |
Why?
|
| Callithrix | 1 | 2014 | 20 | 0.030 |
Why?
|
| Primates | 1 | 2014 | 42 | 0.030 |
Why?
|
| Adolescent | 1 | 2020 | 5822 | 0.020 |
Why?
|
| MicroRNAs | 1 | 2014 | 616 | 0.020 |
Why?
|
| Male | 2 | 2020 | 27727 | 0.020 |
Why?
|
| Brain | 1 | 2014 | 1487 | 0.020 |
Why?
|
| Female | 1 | 2016 | 30695 | 0.010 |
Why?
|